These findings, along with ongoing research, suggest that GLP-1 medications hold significant promise for managing NAFLD/NASH and preventing complications such as cirrhosis and liver failure
Compounded tirzepatide products are not required to undergo the same type of testing, meaning they are not evaluated for safety, effectiveness, or quality in the same way as an FDA-approved drug like Zepbound is
GLP-1 hair loss GLP-1 being a hormone that governs our appetite, which these drugs mimic is a very real side effect
This dysregulated metabolism creates an environment characterized by persistent oxidative stress, chronic inflammation, and altered energy signaling, which collectively drive fibrosis and cellular transformation (Ramaite and Nkadimeng, 2025)
This process is termed as the methyl trap hypothesis